Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japanese Man Falls Unconscious After Taking ED Drug From China 

This article was originally published in PharmAsia News

Executive Summary

A Japanese man in Hiroshima fell unconscious after taking an erectile dysfunction drug made in China that has not been approved in Japan. The man, in his 30s, imported 24 capsules of Nangenzengzhangsu, and took the capsules once a day since the end of January. On Feb. 21, he fell unconsciousness at work and was rushed to the hospital. Two drug ingredients were found in the capsules, blood sugar lowering glibenclamide and sildenafil (the active ingredient in Pfizer's Viagra). The amount of glibenclamide contained in the capsules was found to greatly exceed the allowable level set forth in the Pharmaceutical Law. (Click for more-Japanese language

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067953

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel